Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study. - Canino, Fabio; Barbolini, Monica; De Giorgi, Ugo; Fontana, Tommaso; Gaspari, Valeria; Gianni, Caterina; Gianni, Lorenzo; Maestri, Antonio; Minichillo, Santino; Moscetti, Luca; Mura, Antonella; Nicoletti, Stefania Vittoria Luisa; et al. (BMC Cancer, 2024)